Trust Company of Vermont’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$226K Sell
2,885
-53
-2% -$4.15K 0.01% 334
2025
Q1
$213K Sell
2,938
-190
-6% -$13.8K 0.01% 334
2024
Q4
$232K Buy
3,128
+109
+4% +$8.07K 0.01% 326
2024
Q3
$199K Buy
3,019
+801
+36% +$52.9K 0.01% 330
2024
Q2
$205K Buy
2,218
+25
+1% +$2.31K 0.01% 314
2024
Q1
$210K Buy
2,193
+914
+71% +$87.3K 0.01% 304
2023
Q4
$97.5K Buy
1,279
+4
+0.3% +$305 0.01% 353
2023
Q3
$88.3K Sell
1,275
-72
-5% -$4.99K 0.01% 380
2023
Q2
$127K Hold
1,347
0.01% 362
2023
Q1
$111K Sell
1,347
-112
-8% -$9.27K 0.01% 381
2022
Q4
$109K Buy
1,459
+112
+8% +$8.36K 0.01% 372
2022
Q3
$111K Hold
1,347
0.01% 368
2022
Q2
$128K Buy
+1,347
New +$128K 0.01% 353
2022
Q1
Sell
-1,319
Closed -$171K 445
2021
Q4
$171K Buy
+1,319
New +$171K 0.01% 334
2021
Q3
Sell
-1,319
Closed -$137K 434
2021
Q2
$137K Buy
1,319
+765
+138% +$79.5K 0.01% 356
2021
Q1
$46K Buy
554
+29
+6% +$2.41K ﹤0.01% 470
2020
Q4
$48K Hold
525
﹤0.01% 453
2020
Q3
$42K Sell
525
-150
-22% -$12K ﹤0.01% 449
2020
Q2
$47K Sell
675
-84
-11% -$5.85K ﹤0.01% 445
2020
Q1
$48K Buy
759
+300
+65% +$19K ﹤0.01% 442
2019
Q4
$36K Hold
459
﹤0.01% 517
2019
Q3
$34K Hold
459
﹤0.01% 532
2019
Q2
$28K Hold
459
﹤0.01% 564
2019
Q1
$29K Sell
459
-117
-20% -$7.39K ﹤0.01% 550
2018
Q4
$29K Hold
576
﹤0.01% 547
2018
Q3
$33K Hold
576
﹤0.01% 578
2018
Q2
$28K Buy
+576
New +$28K ﹤0.01% 628
2017
Q1
Sell
-45
Closed -$1K 880
2016
Q4
$1K Buy
+45
New +$1K ﹤0.01% 868